Cambridge Trust’s Rayonier RYN Stock Holding History

Cambridge Trust’s Portfolio RYN Stock Details RYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-71	Closed	-$2.14K	–	712
2023 Q4	$2.14K	Hold	71	–	–	﹤0.01%	658
2023 Q3	$1.82K	Hold	71	–	–	﹤0.01%	670
2023 Q2	$2.01K	Sell	71 -55	-44%	-$1.53K	﹤0.01%	663
2023 Q1	$3.79K	Hold	126	–	–	﹤0.01%	696
2022 Q4	$4K	Hold	126	–	–	﹤0.01%	730
2022 Q3	$3K	Hold	126	–	–	﹤0.01%	761
2022 Q2	$4K	Sell	126 -288	-70%	-$10.6K	﹤0.01%	766
2022 Q1	$15K	Hold	414	–	–	﹤0.01%	704
2021 Q4	$15K	Buy	+414	New	+$14.4K	﹤0.01%	751

Other funds holding RYN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cambridge Trust's RYN Position: Q1 2024 in Review

Cambridge Trust sold out of Rayonier (RYN) in Q1 2024, closing a stake of 71 shares — an estimated $2.14K sold.

Cambridge Trust first reported a position in RYN in Q4 2021 and held it in 9 quarters. The position peaked at $15K in Q1 2022. 336 funds tracked by Wall St. Rank hold RYN as of Q1 2024.

Cambridge Trust reported no remaining Rayonier position as of Q1 2024 after selling out during the quarter.
Cambridge Trust sold 71 Rayonier shares in Q1 2024, an estimated $2.14K.
Cambridge Trust first reported a position in Rayonier in Q4 2021 and held it in 9 quarters.
Cambridge Trust's Rayonier position peaked at $15K in Q1 2022.
336 funds tracked by Wall St. Rank held Rayonier as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.